Literature DB >> 14966364

Attenuation of mouse mesangial cell contractility by high glucose and mannitol: involvement of protein kinase C and focal adhesion kinase.

Jin-Shuen Chen1, Herng-Sheng Lee, Jong-Shiaw Jin, Ann Chen, Shih-Hua Lin, Shuk-Man Ka, Yuh-Feng Lin.   

Abstract

Hyperglycemia and mannitol activate protein kinase C (PKC) and induce mesangial cell hypocontractility that subsequently may modulate renal function. Since focal adhesion kinase (FAK) activation is known to be linked with PKC activity, FAK may also be involved in mesangial cell contraction. To facilitate our understanding of the PKC- and FAK-modulating mechanism, we developed an in vitro model of mouse mesangial cell hypocontractility induced by hyperglycemia or mannitol. Mouse mesangial cells (CRL-1927) were exposed to: normal D-glucose (group N), high D-glucose (group H), and control groups at the same osmolality as H plus L-glucose (group L) and mannitol (group M). Changes in the planar surface area of cells in response to 1 microM phorbol 12-myristate 13-acetate (PMA) were determined. Western blot analyses for PKC, phosphorylated (p)-PKC, tyrosine phosphorylation, FAK, and p-FAK were done on each of these four groups. The effects of mannitol in various doses on cell contraction and activation of PKC and FAK were also assayed. The planar surface areas of groups H and M both showed an attenuated change in response to PMA stimulation. Before PMA stimulation, the baseline PKC expression of groups H and M showed a higher expression of p-PKC alpha and delta than that seen in group N (p < 0.05). Results of tyrosine phosphorylation and immunoprecipitation showed that FAK may be involved in this contraction process. The total amount of FAK showed no significant difference among the four experimental groups; however, p-FAK was found to have significantly increased in group M (p < 0.05). The use of PKC and tyrosine kinase inhibitors reduced PMA-induced mesangial cell contraction in all four groups. Activation of PKC alpha, delta, and FAK with the resultant inhibition of mesangial cell contraction by mannitol was found to be dose-dependent. These results may provide a correlation between increased expression of several PKC isoforms and, in particular, increased phosphorylation levels of PKC alpha and delta and hypocontractility induced by high glucose and mannitol treatment. Furthermore, the mannitol-induced hypocontractility involving PKC and FAK occurred in a dose-dependent manner. Copyright 2004 National Science Council, ROC and S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14966364     DOI: 10.1007/bf02256557

Source DB:  PubMed          Journal:  J Biomed Sci        ISSN: 1021-7770            Impact factor:   8.410


  10 in total

1.  Characterization of the mechanisms of the increase in PPARδ expression induced by digoxin in the heart using the H9c2 cell line.

Authors:  Zhih-Cherng Chen; Bu-Chin Yu; Li-Jen Chen; Kai-Chun Cheng; Hung Jung Lin; Juei-Tang Cheng
Journal:  Br J Pharmacol       Date:  2011-05       Impact factor: 8.739

2.  Effects of mannitol alone and mannitol plus furosemide on renal oxygen consumption, blood flow and glomerular filtration after cardiac surgery.

Authors:  Bengt Redfors; Kristina Swärd; Johan Sellgren; Sven-Erik Ricksten
Journal:  Intensive Care Med       Date:  2008-07-09       Impact factor: 17.440

3.  Emodin ameliorates high-glucose induced mesangial p38 over-activation and hypocontractility via activation of PPARgamma.

Authors:  Yi Liu; Lei Jia; Zun Chang Liu; Hong Zhang; Peng Ju Zhang; Qiang Wan; Rong Wang
Journal:  Exp Mol Med       Date:  2009-09-30       Impact factor: 8.718

Review 4.  Role of T cells in type 2 diabetic nephropathy.

Authors:  Chia-Chao Wu; Huey-Kang Sytwu; Kuo-Cheng Lu; Yuh-Feng Lin
Journal:  Exp Diabetes Res       Date:  2011-10-19

5.  Molecular role of GATA binding protein 4 (GATA-4) in hyperglycemia-induced reduction of cardiac contractility.

Authors:  Po-Ming Ku; Li-Jen Chen; Jia-ru Liang; Kai-Chun Cheng; Yin-Xiao Li; Juei-Tang Cheng
Journal:  Cardiovasc Diabetol       Date:  2011-06-24       Impact factor: 9.951

6.  Involvement of F-actin in chaperonin-containing t-complex 1 beta regulating mouse mesangial cell functions in a glucose-induction cell model.

Authors:  Jin-Shuen Chen; Li-Chien Chang; Chia-Chao Wu; Lai-King Yeung; Yuh-Feng Lin
Journal:  Exp Diabetes Res       Date:  2011-11-15

Review 7.  Mitochondria-targeted drugs for diabetic kidney disease.

Authors:  Akira Mima
Journal:  Heliyon       Date:  2022-02-03

Review 8.  Inflammation and oxidative stress in diabetic nephropathy: new insights on its inhibition as new therapeutic targets.

Authors:  Akira Mima
Journal:  J Diabetes Res       Date:  2013-06-03       Impact factor: 4.011

9.  Hypo- and hyperglycemia impair endothelial cell actin alignment and nitric oxide synthase activation in response to shear stress.

Authors:  Steven Frank Kemeny; Dannielle Solomon Figueroa; Alisa Morss Clyne
Journal:  PLoS One       Date:  2013-06-12       Impact factor: 3.240

10.  High glucose downregulates myocardin expression in rat glomerular mesangial cells via the ERK signaling pathway.

Authors:  Ming Li; Lijuan Xu; Guowei Feng; Yan Zhang; Xin Wang; Yuebing Wang
Journal:  Oncotarget       Date:  2017-08-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.